Population pharmacokinetic (popPK) model of pembrolizumab (pembro; MK-3475) in patients (pts) treated in KEYNOTE-001 and KEYNOTE-002.Tara C. Gangadhar, Adil Daud, Gregory M. Lubiniecki et al.|Journal of Clinical Oncology|2015Cited by 6